| Literature DB >> 18438305 |
M Van Ameringen1, C Mancini, P Farvolden, J Oakman.
Abstract
Social phobia is a common psychiatric disorder that is often associated with significant psychiatric comorbidity and disability. In the past, clinicians have underutilized pharmacotherapy as a treatment option for this disorder. This article provides a review of current pharmacotherapeutic options for social phobia, including a review of the results to date of numerous controlled trials, a description of the recent results of open trials of new and promising agents, and a summary of the information available on the use of pharmacotherapy in the treatment of children and adolescents.Entities:
Year: 1999 PMID: 18438305 DOI: 10.1017/s1092852900012517
Source DB: PubMed Journal: CNS Spectr ISSN: 1092-8529 Impact factor: 3.790